- Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study - The exceptional efficacy of denifanstat ...

HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study (NCT06248008) evaluating denifanstat ...

Abstract: The paper presents an adaptive controller formulated for a class of nonaffine discrete-time systems with non-strict forms and unknown dynamics. The controller operates based solely on the ...

USMNT star Christian Pulisic keeps a balanced perspective despite the major hype surrounding him. Pulisic excels at AC Milan, achieving impressive goal and assist records over multiple seasons. He ...

In this Jan. 23, 2014, file photo, the nutrition facts label on the side of a cereal box is photographed in Washington. (AP Photo/J. David Ake, File) (CN) — A federal judge tossed the bulk of a ...

For the past two years, one of the most talked-about topics at Vogue Runway—and in the industry at large—has been fashion’s big vibe shift. When we started talking about it, we couldn’t have guessed ...

A nationwide recall of ice cream over undeclared milk has received the second-highest warning by the Food and Drug Administration (FDA). Tropicale Foods, based in Ontario, California, issued a ...

The U.S. Food and Drug Administration raised the risk warning of two recalled sugar-free sweetener products for potential health risks to consumers. NuNaturals, Inc. voluntarily recalled 156 bottles ...

Amber is the Associate Editorial Director overseeing news content for Health, ensuring that readers stay up-to-date on trending topics like COVID-19, as well as the most recent research in the health ...

Findings from postmarketing studies showed long-term opioid use was associated with serious risks including misuse, addiction, and overdose. The Food and Drug Administration (FDA) is requiring ...